Atherosclerotic coronary artery disease: Usefulness of C-reactive protein for the identification of the «vulnerable» plaque and the «vulnerable» patient;Enfermedad cardiovascular aterosclerótica: La utilidad de la proteína C reactiva en la identificación de la placa «vulnerable» y del paciente «vulnerable»

Revista Espanola de Cardiologia

Volumn 57, Issue 5, 2004, Pages 375-378

  Arroyo Espiliguero, Ramón ^a   Avanzas, Pablo ^b   Kaski, Juan C ^c  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; EDITORIAL; HEART MUSCLE NECROSIS; HEART PROTECTION; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; INFLAMMATORY INFILTRATE; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL;

EID: 2942702063     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13061113     Document Type: Editorial

References (17)

1. Koenig W, Lowel H, Baumert J, Meisinger C. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation 2004;109:1349-53.
2. Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles S, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001;344:1959-65.
3. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
4. Sabatine MS, Morrow DA, De Lemos JA, Gibson CM, Murphy SA, Rifai N, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002;105:1760-3.
5. Sanchís J, Bodí V, Llácer A, Facila L, Martínez-Brotons A, Insa L, et al. Relación de los valores de proteina C reactiva con los hallazgos angiográficos y los marcadores de necrosis en el síndrome coronario agudo sin elevación del segmento ST. Rev Esp Cardiol 2004;57:382-7.
6. Katritsis D, Korovesis S, Giazitzoglou E, Parissis J, Kalivas P, Webb-Peploe MM, et al. C-reactive protein concentrations and angiographic characteristics of coronary lesions. Clin Chem 2001;47:882-6.
7. Arroyo-Espliguero R, Avanzas P, Cosín-Sales J, Aldama G, Pizzi C, Kaski JC. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J 2004;25:401-8.
8. Avanzas P, Arroyo-Espliguero R, Cosín-Sales J, Aldama G, Pizzi C, Quiles J, et al. Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes [en prensa]. Heart 2004.
9. Avanzas P, Arroyo-Espliguero R, Cosín-Sales J, Quiles J, Zouridakis E, Kaski JC. Multiple complex stenoses, high neutrophil count and C-Reactive protein levels in patients with chronic stable angina [en prensa]. Atherosclerosis 2004.
10. Maehara A, Mintz GS, Bui AB, Walter OR, Castagna MT, Canos D, et al. Morphologic and angiographic features of coronary plaque rapture detected by intravascular ultrasound. J Am Coll Cardiol 2002;40:904-10.
11. Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 2002;347:5-12.
12. Rioufol G, Finet G, Ginon I, Andre-Fouet X, Rossi R, Vialle E, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 2002;106:804-8.
13. Asakura M, Ueda Y, Yamaguchi O, Adachi T, Hirayama A, Hori M, et al. Extensive development of vulnerable plaques as a pancoronary process in patients with myocardial infarction: an angioseopic study. J Am Coll Cardiol 2001;37:1284-8.
14. Zairis M, Papadaki O, Manousakis S, Thoma M, Beldekos D, Olympios C, et al. C-reactive protein and multiple complex coronary artery plaques in patients with primary unstable angina. Atherosclerosis 2002;164:355-9.
15. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
16. Chew DP, Bhatt DL, Robbins MA, Penn MS, Schneider JP, Lauer MS, et al. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 2001;104:992-7.
17. Kaski JC, Cruz-Fernández JM, Fernández-Bergés D, García-Moll X, Martín Jadraque L, Mostaza J, et al. Marcadores de inflamación y estratificación de riesgo en pacientes con síndrome coronano agudo: diseño del estudio SIESTA (Systemic Inflammation Evaluation in patients with non-ST segment elevation Acute coronary syndromes). Rev Esp Cardiol 2003;56:389-95.